Balta, Victoria A. http://orcid.org/0000-0003-0685-6697
Stiffler, Deborah
Sayeed, Abeer
Tripathi, Abhai K. http://orcid.org/0000-0001-9848-0142
Elahi, Rubayet
Mlambo, Godfree
Bakshi, Rahul P.
Dziedzic, Amanda G.
Jedlicka, Anne E. http://orcid.org/0000-0003-3826-2973
Nenortas, Elizabeth
Romero-Rodriguez, Keyla
Canonizado, Matthew A.
Mann, Alexis
Owen, Andrew http://orcid.org/0000-0002-9819-7651
Sullivan, David J. http://orcid.org/0000-0003-0319-0578
Prigge, Sean T. http://orcid.org/0000-0001-9684-1733
Sinnis, Photini http://orcid.org/0000-0003-2954-7547
Shapiro, Theresa A. http://orcid.org/0000-0002-6823-7536
Article History
Received: 13 March 2023
Accepted: 27 September 2023
First Online: 12 October 2023
Competing interests
: R.P.B., G.M., A.O., T.A.S., and A.K.T. are coinventors on PCT/GB2017/051746 (Atovaquone long-acting injectable formulation). A.O. is Director of Tandem Nano Ltd; received personal fees from Gilead and Assembly Biosciences; and is co-investigator on funding received by the University of Liverpool from ViiV Healthcare and Gilead Sciences. D. J. S. is Founder, Board Member, and stock/option owner of AliquantumRx; an expert legal consultant for Mabery Legal Firm; coinventor on USP 7,270,948 (Detection of malaria parasites by laser desorption mass spectrometry), USP9,568,471 (Malaria diagnosis in urine), USP 9,642,865 (New angiogenesis inhibitors), and PCT/US2015/046665 (Salts and polymorphs of cethromycin for the treatment of disease); and has received royalties from Binax Inc/D/B/A Inverness Medical for plasmids for HRP aldolase for malaria diagnostic kit. The remaining authors declare no competing interests.